Integra LifeSciences | IART - Ebitda



金融业
股票价格
USD
资产
USD 3.6B
现金及等价物
USD 235.05M
销售成本
USD 193.45M
流动资产
USD 1.16B
流动负债
USD 455.98M
债务
USD 2.01B
EBIT
USD 66.01M
EBITDA
USD 104.21M
员工
4.4K
EPS每股收益
USD 0.83
股本和储备
USD 1.04B
销售毛利
USD 217.1M
债务利息支出
USD 23.67M
利息收入
USD 4.98M
贷款资金
USD 1.86B
市值
USD 696.2M
净收入
USD -1.7M
营业费用
USD 368.92M
营业利润
USD 66.01M
普通股股本
USD 77.89M
PE价格收益
6.59
税前利润
USD -6.82M
销售收入
USD 434.9M
销售和管理费用
USD 156.45M
股票
USD 492.74M
贸易债权人
USD 95.73M
应收帐款人
USD 278.85M


Ebitda 更改 日
Abbott USD 3.09B 44M 2025-09
AtriCure USD 19.86M 2.06M 2025-12
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
CONMED USD 80.36M 49.87M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Globus Medical USD 280.46M 27.86M 2025-12
HeartBeam USD 2.71M 8.21M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 919.7M 21M 2025-09
J&J USD 9.52B 389M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Orthofix International USD 27.88M 2.77M 2025-12
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12